Skip to main content
Clinical Trials/EUCTR2019-004750-28-BE
EUCTR2019-004750-28-BE
Active, not recruiting
Phase 1

Electrocardiographic And Clinical Effects Of Target-Controlled Infusion Of Propofol In Adults With Brugada Syndrome. A Pilot Study.

niversitair Ziekenhuis Brussel0 sites5 target enrollmentApril 1, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Ziekenhuis Brussel
Enrollment
5
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversitair Ziekenhuis Brussel

Eligibility Criteria

Inclusion Criteria

  • \- Age \= 18 year
  • \- ASA 2, 3 or 4
  • \- Elective surgery
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 4
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 1

Exclusion Criteria

  • \- Known allergy to propofol
  • \- Severe cerebral pathology
  • \- Ketamine administration
  • \- Nitrous Oxide administration
  • \- Successful performed locoregional block prior to surgery
  • \- BMI \> 35 for female patients
  • \- BMI \> 42 for male patients
  • \- Obstetric anaesthesia
  • \- Critical Illness
  • \- Mitochondrial disease

Outcomes

Primary Outcomes

Not specified

Similar Trials